VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
DH
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
DHDefinitive Healthcare Corp.
$0.72$76M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksDHBalance Sheet

Definitive Healthcare Corp. (DH) Balance Sheet

7Y historyFree accessUpdated daily

The company's financial position reflects significant retrenchment, with total assets contracting from $1.8 billion in 2023Q4 to $514.7 million in 2026Q1, alongside a debt-to-equity ratio of 0.89.

DH Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19
Total Current Assets233.31M257.61M370.17M380.44M413.75M444.23M63.84M36.11M
Cash & Short-Term Investments178.09M180.89M290.16M308.07M331.87M387.5M24.77M8.62M
Cash Only157.65M163.63M105.38M130.98M146.93M387.5M24.77M8.62M
Short-Term Investments20.45M17.26M184.79M177.09M184.94M000
Accounts Receivable39.36M51.98M53.23M59.25M58.8M43.34M33.11M25.02M
Days Sales Outstanding62.7278.5577.0486.0296.3995.2102.14106.81
Inventory00000000
Days Inventory Outstanding--------
Other Current Assets155K24.74M26.78M13.12M23.07M6.88M2.95M769K
Total Non-Current Assets281.42M477.89M719.22M1.43B1.71B1.67B1.68B1.69B
Property, Plant & Equipment18.68M18.07M11.31M14.06M14.14M5.07M3.25M2.56M
Fixed Asset Turnover13.30x13.36x22.30x17.88x15.74x32.78x36.43x33.43x
Goodwill0197.22M393.28M1.08B1.32B1.26B1.26B1.23B
Intangible Assets235.43M247.48M297.93M323.12M350.72M352.47M410.24M446.38M
Long-Term Investments949K00509K032.67M5.95M0
Other Non-Current Assets26.76M15.12M16.69M19.2M19.28M19.94M472K2.72M
Total Assets514.74M735.49M1.09B1.83B2.12B2.12B1.75B1.72B
Asset Turnover0.34x0.33x0.23x0.14x0.10x0.08x0.07x0.05x
Asset Growth %-150.75%-32.49%-40.34%-13.98%0.24%21.33%1.41%-
Total Current Liabilities140.4M156.79M161.16M170.68M140.61M123.12M88.72M69.92M
Accounts Payable6.02M3.6M10.76M5.79M3.95M4.65M5.66M2.16M
Days Payables Outstanding36.3922.5371.7844.4933.8141.7267.8318.29
Short-Term Debt11.41M11.43M13.75M13.75M8.59M6.88M4.68M4.5M
Deferred Revenue (Current)388.9M96.99M93.34M97.38M99.69M83.61M61.64M45.98M
Other Current Liabilities16.73M44.77M25.21M38.72M3.16M2.97M2.08M338K
Current Ratio1.66x1.64x2.30x2.23x2.94x3.61x0.72x0.52x
Quick Ratio1.66x1.64x2.30x2.23x2.94x3.61x0.72x0.52x
Cash Conversion Cycle26.33-------
Total Non-Current Liabilities183.64M199.71M321.03M456.05M500.07M494.66M461.07M435M
Long-Term Debt153.99M161.24M229.37M242.57M255.76M263.81M457.2M434.85M
Capital Lease Obligations21.87M5.15M7.59M9.37M9.97M000
Deferred Tax Liabilities54.56M14.63M25.09M67.16M75.74M76.4M00
Other Non-Current Liabilities14M16.31M58.96M136.93M158.36M154.04M3.74M0
Total Liabilities324.04M356.5M482.19M626.73M640.68M617.78M549.8M504.91M
Total Debt169.84M177.82M253.11M267.93M275.85M270.68M461.88M439.35M
Net Debt12.19M14.19M147.73M136.95M128.91M-116.81M437.1M430.73M
Debt / Equity0.89x0.47x0.42x0.22x0.19x0.18x0.39x0.36x
Debt / EBITDA0.81x11.67x--21.45x8.30x10.57x14.01x
Net Debt / EBITDA0.06x0.93x--10.02x-3.58x10.00x13.73x
Interest Coverage-3.42x-17.54x-41.71x-19.27x-2.74x-1.42x-0.44x-0.98x
Total Equity190.7M378.99M607.19M1.2B1.48B1.5B1.2B1.22B
Equity Growth %-191.41%-37.58%-49.37%-19.08%-1.19%25.45%-1.7%-
Book Value per Share1.823.555.2110.6314.6615.4612.328.16
Total Shareholders' Equity146.23M281.11M444.38M861.36M948.92M871.31M1.2B1.22B
Common Stock105K104K114K117K105K97K1.31B1.27B
Retained Earnings-918.13M-779.51M-640.57M-227.45M-25.06M-17.84M-109.86M-55.76M
Treasury Stock00000000
Accumulated OCI-1.55M-1.45M-610K2.11M3.67M62K-131K0
Minority Interest44.47M97.88M162.82M337.82M533.03M628.52M00

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetHealthy
Cash FlowBurning
Top Statement Risk

Persistent Revenue Contraction

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Asset Base Contraction Signals Retrenchment

As reported in financial statements, Definitive Healthcare’s total assets have declined from $1.8 billion in 2023Q4 to $514.7 million in 2026Q1, reflecting a significant reduction in the company’s balance sheet footprint that appears to correlate with ongoing challenges in maintaining top-line growth and operational scale.

The sharp reduction in total assets, largely driven by the impairment or write-down of goodwill, suggests that previous acquisition-led growth strategies are being reassessed. Investors should monitor whether this contraction represents a necessary rightsizing of the business or a more concerning erosion of the company's competitive infrastructure.

Goodwill Impairment Risks Asset Quality

Based on the provided quarterly data, goodwill has plummeted from $1.1 billion in 2023Q4 to $235.4 million in 2026Q1, indicating that the carrying value of past acquisitions is being aggressively adjusted downward to reflect current market realities and the company's diminished growth prospects.

The concentration of assets in intangible form historically masked the true economic value of the platform, and the recent write-downs suggest that the premium paid for historical growth is no longer supported by current performance. This shift implies that the asset base is becoming less reliant on acquisition-driven intangibles and more focused on the underlying data platform.

Retained Earnings Deficit Weighs Heavily

According to recent SEC filings, Definitive Healthcare’s retained earnings have deteriorated significantly, reaching a deficit of $918.1 million in 2026Q1, which highlights the persistent impact of cumulative net losses on the company’s total equity position over the last ten quarters.

The consistent expansion of the retained earnings deficit suggests that the business model has yet to reach a point of self-sustaining profitability. This trend warrants further investigation into whether the current equity structure can support future operational needs without requiring further dilution or external financing.

Cash Runway Amidst Operational Burn

As reported in financial statements, the company maintains a cash position of $157.6 million as of 2026Q1, providing a liquidity buffer that appears adequate for near-term operations despite the ongoing pressure from negative net margins and the lack of consistent free cash flow generation.

While the current ratio of 1.66 suggests sufficient short-term liquidity, the reliance on cash reserves to fund operations is a critical vulnerability. Investors should monitor the burn rate closely, as the absence of positive cash flow from operations may eventually necessitate a pivot in capital allocation strategy.

Leverage Remains Modest Despite Losses

Based on reported figures, Definitive Healthcare maintains a debt-to-equity ratio of 0.89 as of 2026Q1, which, while higher than historical levels, suggests that the company has not yet resorted to aggressive debt financing to offset its persistent operational deficits.

The company’s debt profile appears manageable in the context of its current cash position, yet the rising D/E ratio reflects the shrinking equity base rather than an increase in absolute debt. This suggests that management is maintaining a conservative leverage profile, which may be a strategic choice to preserve flexibility.

DH — Frequently Asked Questions

Quick answers to the most common questions about buying DH stock.

What are the total assets of Definitive Healthcare Corp. (DH)?

As of 2025, Definitive Healthcare Corp. (DH) had total assets of $735.5M including $257.6M in current assets.

How much debt does Definitive Healthcare Corp. (DH) have?

Definitive Healthcare Corp. (DH) carries total debt of $177.8M, offset by $180.9M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Definitive Healthcare Corp.?

Definitive Healthcare Corp. (DH) has total shareholders' equity (book value) of $281.1M ($3.55 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Definitive Healthcare Corp.'s current ratio and liquidity?

Definitive Healthcare Corp. (DH) reported a current ratio of 1.64x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.